Search research articles
Contact Us
Filters
Showing results (21-30 of 28) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 28 results.
European Journal of Cancer (Oxford, England : 1990)
|
July 27, 2024
Toward a comprehensive solution for treating solid tumors using T-cell receptor therapy: A review
Peiwen Ma, Yale Jiang, Guo Zhao, et al.
Vaccines
|
July 27, 2022
Identification of Tumor Antigens and Immune Subtypes of Malignant Mesothelioma for mRNA Vaccine Development
Shuhang Wang, Yuqi Yang, Lu Li, et al.
Frontiers of Medicine
|
May 15, 2023
Rare tumors: a blue ocean of investigation
Shuhang Wang, Peiwen Ma, Ning Jiang, et al.
Med (New York, N.Y.)
|
May 10, 2025
Learning from the LEAP trial series: Optimizing clinical trial design for combination therapies
Jiatong Ding, Yue Yu, Dandan Cui, et al.
EMBO Molecular Medicine
|
November 28, 2022
Targeting rare tumors: new focus for clinical research in China
Shuhang Wang, Yale Jiang, Huilei Miao, et al.
EMBO Molecular Medicine
|
August 25, 2021
The state of the art of bispecific antibodies for treating human malignancies
Shuhang Wang, Kun Chen, Qi Lei, et al.
Brain : a Journal of Neurology
|
November 8, 2024
Bridging the gap: unlocking the potential of emerging drug therapies for brain metastasis
Jiatong Ding, Yale Jiang, Ning Jiang, et al.
The Lancet Regional Health. Western Pacific
|
November 25, 2022
The reliability and integrity of overall survival data based on follow-up records only and potential solutions to the challenges
Huiyao Huang, Yu Tang, Yue Yu, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 28) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 28 results.
European Journal of Cancer (Oxford, England : 1990)
|
July 27, 2024
Toward a comprehensive solution for treating solid tumors using T-cell receptor therapy: A review
Peiwen Ma, Yale Jiang, Guo Zhao, et al.
Vaccines
|
July 27, 2022
Identification of Tumor Antigens and Immune Subtypes of Malignant Mesothelioma for mRNA Vaccine Development
Shuhang Wang, Yuqi Yang, Lu Li, et al.
Frontiers of Medicine
|
May 15, 2023
Rare tumors: a blue ocean of investigation
Shuhang Wang, Peiwen Ma, Ning Jiang, et al.
Med (New York, N.Y.)
|
May 10, 2025
Learning from the LEAP trial series: Optimizing clinical trial design for combination therapies
Jiatong Ding, Yue Yu, Dandan Cui, et al.
EMBO Molecular Medicine
|
November 28, 2022
Targeting rare tumors: new focus for clinical research in China
Shuhang Wang, Yale Jiang, Huilei Miao, et al.
EMBO Molecular Medicine
|
August 25, 2021
The state of the art of bispecific antibodies for treating human malignancies
Shuhang Wang, Kun Chen, Qi Lei, et al.
Brain : a Journal of Neurology
|
November 8, 2024
Bridging the gap: unlocking the potential of emerging drug therapies for brain metastasis
Jiatong Ding, Yale Jiang, Ning Jiang, et al.
The Lancet Regional Health. Western Pacific
|
November 25, 2022
The reliability and integrity of overall survival data based on follow-up records only and potential solutions to the challenges
Huiyao Huang, Yu Tang, Yue Yu, et al.
Page
of 3